References
- Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256: 495–497
- Levy R, Miller R A. Tumor therapy with monoclonal antibodies. Fed Proc 1983; 42: 2650–2656
- Robins R A, Baldwin R W. T-cell subsets in tumor rejection responses. Immunol Today 1985; 6: 55–58
- Biddison W E, Rao P E, Talle M A, Goldstein G, Shaw S J. Possible involvement of the OKT4 molecule in T-cell recognition of class II HLA antigens. J Exp Med 1982; 156: 1065–1076
- Engleman E G, Benike C J, Grumet F C, Evans R L. Activation of human T lymphocyte subsets: Helper and suppressor/cytotoxic T cells recognize and respond to distinct histocompatibility antigens. J Immunol 1981; 127: 2124–2129
- Dialynas D P, Quan Z S, Wall K A, et al. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK 1.5: Similarity of L3T4 to the human Leu-3/T4 molecule. J Immunol 1983; 131: 2445–2451
- Dialynas D P, Wilde D B, Marrack P, et al. Characterization of the murine antigenic determinent, designated L3T4a, recognized by monoclonal antibody GK 1.5: Expression of L3T4a by functional T-cell clones appears to correlate primarily with class II MHC antigen reactivity. Immunol Rev 1983; 74: 29–56
- Swain S L, Dialynas D P, Fitch F W, English M. Monoclonal antibody to L3T4 blocks the function of T cells specific for class II major histocompatibility complex antigens. J Immunol 1984; 132: 1118–1123
- Swain S L. T-cell subsets and the recognition of MHC class. Immunol Rev 1983; 74: 129–142
- Wilde D B, Marrack P, Kappler J, et al. Evidence implicating L3T4 in class II MHC antigen reactivity, monoclonal antibody GK 1.5 (anti L3T4a) blocks class II HMC antigen-specific proliferation, release of lymphokines, and binding by cloned murine helper T lymphocyte lines. J Immunol 1983; 131: 2178–2183
- Waldor M K, Sriram S, Hardy R, et al. Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T cell subset marker. Science 1985; 227: 415–417
- Wofsky D, Seaman W E. Successful treatment of autoimmunity of NZB/NZW D, mice with monoclonal antibody to L3T4. J Exp Med 1985; 161: 378–391
- Ledbetter J A, Herzenberg L A. Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol Rev 1979; 47: 63–90
- Femandez-Cruz E, Cruz S C, Feldman J D. Immunotherapy of a chemically-induced sarcoma in rats: Characterization of the effector T-cell subset and nature of suppression. J Immunol 1982; 128: 1112–1117
- Nelson M, Nelson D S, McKenzie I FC, Blanden R V. Thy and Ly markers on lymphocytes initiating tumor rejection. Cell Immunol 1981; 60: 34–42
- Farrar J J, Benjamin W R, Hilfiker M L, et al. The biochemistry, biology and role of interleukin-2 in the induction of cytotoxic T-cell and antibody-forming B-cell respones. Immunol Rev 1982; 63: 129–166
- Rook A H, Masur H, Lane H C, et al. Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome. J Clin Invest 1983; 72: 398–403